BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2003
View Archived Issues
New bradykinin B2 antagonists and their use as analgesics reported by AstraZeneca
Read More
Piperazine orexin antagonists in early development at GSK
Read More
New JNK inhibitors with utility in AD therapy reported in recent patent
Read More
Gruenenthal patent covers new alpha2A-AR ligands for pain and other uses
Read More
Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists
Read More
AstraZeneca claims new cannabinoid CB1 receptor modulators
Read More
New alpha7 nAChR agonists under study at Bayer
Read More
AVP-893: a prototype of a novel class of antitumor agents designed at Avanir
Read More
Selective small-molecule inhibitors of CDK4 identified at Roche
Read More
Roche presents new series of antitumor agents targeting CDK2
Read More
Orally available Src tyrosine kinase inhibitor characterized in vitro and in vivo
Read More
Further preclinical characterization of AG-013736, a VEGFR/PDGFR TK inhibitor
Read More
VEGF receptor tyrosine kinase inhibitor E-7080, a promising agent for solid tumors
Read More
Efaproxiral reported to improve survival in cancer patients with brain metastases
Read More
MEDI-507 proven effective in a murine model of adult T-cell leukemia
Read More
Improved survival with carvedilol compared to metoprolol in chronic heart failure
Read More
Synthetic Hsp90 ATPase inhibitor identified as potential new lead anticancer agent
Read More
Barrier Therapeutics licenses oral vitamin D3 derivative
Read More
Genmab expands pipeline with hepatitis antibody
Read More
Phase II clinical trial of advanced malaria vaccine to begin in Mozambique
Read More
United Therapeutics files IND for i.v. Remodulin
Read More
Encouraging results from ongoing phase I/II trial with MetXia in breast cancer
Read More
Aastrom Biosciences receives third NIH grant for stem cell research
Read More
FDA clears phase I study of PHP as an adjunct to IL-2 cancer therapy
Read More
